Trial NCT04032704

View at ClinicalTrials.gov 
Org. Study IDs: SGNLVA-005

Last trial update was posted on 2024-04-17

MeSH Interventions

Pembrolizumab SGN-LIV1A

MeSH Conditions

Adenocarcinoma Carcinoma Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Esophageal Squamous Cell Carcinoma Lung Neoplasms Small Cell Lung Carcinoma Squamous Cell Carcinoma of Head and Neck

Other Conditions

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Head and Neck Squamous Cell Carcinoma Melanoma Non-small Cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer, Squamous Prostate Cancer Small Cell Lung Cancer

Stopping Reasons

Study closed due to portfolio prioritization

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID